Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (67)

2024

  1. An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma

    Cell Reports Methods, Vol. 4, Núm. 3

  2. T-cell immune profile in blood of systemic mastocytosis: Association with disease features

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 7, pp. 1921-1937

2023

  1. Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects

    Cancers, Vol. 15, Núm. 1

  2. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

    Blood Cancer Journal

  3. Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system

    Molecular Neurodegeneration, Vol. 18, Núm. 1

  4. Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge

    The Journal of clinical investigation, Vol. 133, Núm. 5

  5. Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations

    Frontiers in Immunology, Vol. 14

2022

  1. Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination

    Vaccines, Vol. 10, Núm. 2

  2. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood

    Frontiers in Immunology, Vol. 13

  3. Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting

    Frontiers in Medicine, Vol. 9

  4. Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the human thymus

    Science immunology, Vol. 7, Núm. 77, pp. eade0182

2021

  1. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

    Modern Pathology, Vol. 34, Núm. 1, pp. 59-69

  2. COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 5, pp. 2083-2086

  3. GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

    Blood, Vol. 138, Núm. 17, pp. 1590-1602

  4. Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination

    Frontiers in immunology, Vol. 12, pp. 666953

  5. Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome

    Blood, Vol. 138, Núm. 24, pp. 2539-2554

  6. Monocyte subsets and serum inflammatory and bone-associated markers in monoclonal gammopathy of undetermined significance and multiple myeloma

    Cancers, Vol. 13, Núm. 6, pp. 1-18

2020

  1. Corrigendum to “Flow cytometric assessment of leukocyte kinetics for the monitoring of tissue damage” [Clin Immunol 2018; 197: 224–230] (Clinical Immunology (2018) 197 (224–230), (S1521661618301207), (10.1016/j.clim.2018.09.014))

    Clinical Immunology

2019

  1. Bone marrow mast cell antibody-targetable cell surface protein expression profiles in systemic mastocytosis

    International Journal of Molecular Sciences, Vol. 20, Núm. 3

  2. Distribution of subsets of blood monocytic cells throughout life

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 1, pp. 320-323.e6